Vuoi passare al contenuto? Vai ai contenuti
B2B Solutions Convatec Group Contact Us Logo principale Brasil Brasil United States (English) United States (English) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador Estados Unidos (Español) Estados Unidos (Español) United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Portugal Portugal Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国 中国 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
Logo principale Logo principale False /oidc-signin/it-it/ B2B Solutions Convatec Group Contact Us Logo principale Brasil Brasil United States (English) United States (English) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador Estados Unidos (Español) Estados Unidos (Español) United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Portugal Portugal Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国 中国 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))

Terapia infusionale

Aree terapeutiche per l’infusione sottocutanea con set per infusione neria™
a close-up of a syringe

Aree terapeutiche per l’infusione sottocutanea con set per infusione neria™

I set per infusione neria™ sono dispositivi per infusione sottocutanea testati in-vitro e approvati per l’infusione di farmaci nel trattamento della malattia di Parkinson1, della talassemia2 e dell’immunodeficienza primitiva3 e nella gestione del dolore4,5

Maggiori informazioni sui set per infusione neria™ sono disponibili qui

Somministrazione sottocutanea del farmaco 

L’infusione sottocutanea rilascia il farmaco per un periodo prolungato nel tessuto adiposo sotto la cute, dove viene assorbito dall’organismo. La procedura prevede l’inserimento nella pelle di un ago collegato a una catetere morbido. L’ago o il catetere viene poi lasciato nel tessuto per un tempo variabile, da poche ore fino a 72 ore. Aghi e cannule possono variare in lunghezza, dimensioni, caratteristiche e metodo di inserimento. I set per infusione eliminano la necessità di una o più iniezioni giornaliere di un farmaco specifico.

1 Stability test and function test of Comfort and Contact Detach by means of the medicament APO-go. Analysis report no. 294690. January 14-April 1, 2009. Data on file. Unomedical.
2 Drug Device Stability Test Thalaset – Study Desferal (deferoxamine mesilate). July 1, 2005. Data on file. Unomedical.
3 Compatibility and stability testing of the catheter device Unomedical comfort™ with the immunoglobulin Subcuvia. IKFE 09016. April 16, 2009. Data on file. Unomedical.
4 Drug Compatibility Study of Three Infusion Devices with Morphine Sulfate, version 1.4, IKFE 10006, September 2, 2011, Data on File. Unomedical.
5 Drug Compatibility Study of Three Infusion Devices with Hydromorphone Hydrochloride, version 1.4, IKFE 10006, September 2, 2011, Data on File. Unomedical.

Vuoi saperne di più?

Esplora l’universo dei set per infusione neria™

Scopri di più Neria

Supporto
Contattaci
Convatec si impegna a mostrare sempre le informazioni e i dati più recenti, quindi le nostre pagine Web vengono continuamente riviste e aggiornate per garantire che dispongano delle informazioni più aggiornate e pertinenti

Attenzione

Non sono un operatore